Benefit Street Partners
Benefit Street Partners (BSP) is an alternative credit investor based in the United States. The firm is a pioneer in the field of alternative credit and functions as a subsidiary of Franklin Templeton but retains operational independence. BSP boasts a robust team of investment professionals and offers worldwide expertise in the credit market, focusing on direct lending, structured credit, liquid credit, special situations, infrastructure debt, and real estate. Its team benefits from the institutional scale and resources that come from being part of one of the largest asset management firms in the world. What sets BSP apart is its dedication exclusively to the credit market and its ability to leverage Franklin Templeton's extensive network and resources while maintaining a focused and specialized approach to investments.
BSP invests in sectors such as Infrastructure Debt, Real Estate, and various credit categories. The company tends to partake in larger scale investments, driven by its substantial asset base. With $93 billion in assets under management as of 2026, BSP primarily operates within North America. Benefit Street Partners is renowned for its focus on credit solutions, risk-adjusted returns, and providing long-term value to its worldwide clients.
Some noteworthy investments include its milestone CLO 50 with $500 million and involvement in the broader Specialty Finance sector. The firm emphasizes responsible investing and generally adopts a strategy that aligns client investments with social and governance considerations. Through its specialist expertise and global reach, BSP continues to influence the alternative credit market significantly.
Benevolent Capital
Benevolent Capital is a family office and investment firm founded in 2005 by Brett and Grant Johnson. Based in the United States, the firm invests across a range of asset classes including private equity and venture capital. The team consists of experienced professionals with backgrounds in operating and managing successful companies, with a focus on partnering with entrepreneurs and management teams. What sets them apart is their structure where they do not take a management fee from their LPs and only earn a promote after a 2x return on invested capital.
Benevolent Capital focuses on investments in sectors such as real estate, sports franchises, consumer products, and technology. They have a diversified portfolio, investing in early-stage to growth-stage companies. Their investment size ranges across the spectrum, and they maintain a global outlook, targeting opportunities primarily in North America and Europe. The firm is involved with notable companies like Enzymatics, Phoenix Rising FC, and ArcherDX.
Their portfolio includes various companies such as Enzymatics - a biotech firm acquired by Invitae, Oura Ring - a wearable technology company, and Athletic Brewing - a provider of non-alcoholic beers. Other investments include Seekr, an AI-powered search engine, and Chamberlain Coffee, a Gen Z-focused brand. They have a reputation for successful exits and strategic partnerships.
Benhamou Global Ventures
Benhamou Global Ventures (BGV) is a venture capital firm deeply rooted in the heart of Silicon Valley. Founded by immigrant entrepreneurs-turned-venture-capitalists, BGV brings over 300 years of combined operating experience to the table. The team is known for its emphasis on cross-border partnerships and the ability to leverage a global network of resources, speaking multiple languages and understanding diverse cultures. This unique approach sets them apart in the venture capital landscape.
BGV focuses on investing in Enterprise 5.0 companies that are addressing challenges in enterprise automation by combining intelligent machines with human ingenuity. They invest at stages from seed to IPO. Their geographic focus spans globally, while maintaining a strong presence in Silicon Valley. BGV has successfully raised over $2 billion in capital and maintains a robust portfolio of more than 50 companies.
Notable investments include Aidash - AI-based infrastructure management, ThetaRay - AI-powered cybersecurity, MindsDB - machine learning framework, Covu - AI-driven insurance consultancy, and SandboxAQ - quantum computing security solutions. BGV's investment strategy centers around enhancing productivity, decision-making and driving new revenue streams through its Enterprise 5.0 framework.
Bennu Venture Group
Bennu Venture Group, LLC. is a stage agnostic venture capital firm that partners with proven entrepreneurs and established, leading venture capital investors to invest in disruptive rapidly growing enterprises. Established in 2011, Bennu’s principals have 80+ years of experience in the venture capital industry and its relationships date back to the mid 1980s.
Benson Oak Capital
Established the new fund with over 20 years of experience across industries under Benson Oak Capital with our flagship investment in AVG. Our founder focus means we look for every conceivable way to add value pre-investment, during due diligence and on a deeper more involved level with our portfolio companies.
Berg Capital Group
Founded in 2014 by successful serial entrepreneurs, we invest in high quality teams to ensure rapid growth while mitigating risk through close engagement.Angels not sharks. Shared success through collaboration. Carefully curated portfolios. Disciplined investment in post-revenue high growth companies led by successful entrepreneurs. We know the mid-Atlantic markets, and we know which technologies will be needed in the local economy that will scale to national and global potential. So what does our average start-up company look like? Revenue generating at six figures, experienced and accomplished entrepreneurs, unique products and technologies, planned and attainable exit strategies.
Bering Capital
Bering Capital is a venture capital firm based in San Francisco, California, founded in 2020 by Evgeny Zaytsev and Philip Sawyer. The firm focuses on investing in innovative biotech and medical technology companies. With a team of five professionals, including two partners, Bering Capital is committed to supporting the growth of cutting-edge healthcare solutions.
The firm primarily invests in life sciences, healthtech, and enterprise applications, targeting Series C and Series D rounds. Bering Capital's investments are concentrated in the United States, and the firm manages Bering Capital Fund I with an AUM of $50 million, launched in 2021. The firm is a Registered Investment Adviser (RIA) and actively seeks new investment opportunities.
Notable portfolio companies include Coherus Biosciences - biopharmaceuticals, Atea Pharmaceuticals - antiviral therapeutics, CalciMedica - drug discovery, Dragon Vascular - vascular solutions, and Life Detection Technologies - monitoring equipment.
Beringea
Beringea is a transatlantic venture capital investor that seeks to create lasting success for entrepreneurial companies. With offices in Detroit, London and Manchester (UK) and over $715 million under management in the United States and United Kingdom, we provide patient capital and a global footprint to back founders throughout their journey, helping them overcome barriers to scale and build international success stories.
<br />
<br />
Our track record of three decades of successful investing across every major industry has inspired our own entrepreneurial ethos; cultivated an exceptional network throughout the technology and investment communities; and fostered the experience required to create meaningful businesses and deliver value for our shareholders.
Beringer Capital
Beringer Capital is a private equity firm based in Toronto, established in 2002 by entrepreneurs and former executives from the Marketing, Information, and Technology sectors. The firm has over 20 professionals skilled in identifying opportunities in tech-enabled services and digital transformation. Beringer differentiates itself through its active, partnership-driven approach to building enterprise value and its focus on long-term secular trends.
The firm specializes in investing in the North American lower mid-market, focusing on high-growth companies with potential for digital transformation. Their investment strategy targets sectors such as tech platforms, SaaS, and information-led services, deploying control equity investments ranging from $20-100 million. Beringer Capital operates with $1.2 billion in assets under management spread across three established funds.
Notable investments by Beringer Capital include Adweek, Hypergiant, Perform[cb], Dig Insights, and VeraData. These investments underscore their commitment to innovative companies in media, AI, performance marketing, and analytics sectors.
Berkeley Catalyst Fund
Berkeley Catalyst Fund is a venture capital firm based in the San Francisco Bay Area. Founded by Dr. Ted Hou, Mr. Drew Lanza, and Dr. Laura Smoliar, the fund collaborates closely with UC Berkeley and other local institutions to support the startup ecosystem. Each founding partner brings a wealth of experience in fields like chemistry and entrepreneurship. The fund is uniquely positioned to benefit from its strong ties to the academic community, allowing it to leverage talent and resources from UC Berkeley and associated incubators and accelerators.
The fund primarily invests in life sciences, biotechnology, agriculture, cleantech, and sensors with a focus on Seed and Series A stages. Although specific check sizes are not mentioned, the fund is structured to finance early-stage ventures within its thematic focus areas. Additionally, Berkeley Catalyst Fund has a unique relationship with the UC Berkeley Foundation, which acts as a Special Limited Partner, thereby funneling benefits back to the university community.
Notable investments include companies like Mobius Photonics, which specializes in lasers, and other startups in biotechnology and cleantech. Berkeley Catalyst is also supported by a philanthropic sister fund, the Berkeley Catalyst Philanthropic Fund, which contributes to initiatives benefitting UC Berkeley's College of Chemistry through donations and alumni engagement.